Login / Signup

Efficacy and safety of pyronaridine-artesunate (PYRAMAX) for the treatment of P. falciparum uncomplicated malaria in African pregnant women (PYRAPREG): study protocol for a phase 3, non-inferiority, randomised open-label clinical trial.

Moussa DjimdeJaphet Kabalu TshiongoHypolite Mavoko MuhindoHalidou TintoEsperanca SeveneMaminata TraoreAnifa ValaSalesio MacuacuaBerenger KaboreEdgard Diniba DabiraAnnette ErhartHamadoun DiakiteMohamed KeitaMireia PiquerasRaquel GonzalezClara MenendezThomas Pc DorloIssaka SagaraPetra MensHenk SchalligUmberto D'AlessandroKassoum Kayentao
Published in: BMJ open (2023)
PACTR202011812241529.
Keyphrases
  • open label
  • clinical trial
  • pregnant women
  • phase ii
  • study protocol
  • phase iii
  • phase ii study
  • double blind
  • randomized controlled trial
  • plasmodium falciparum
  • combination therapy
  • replacement therapy